Skip to main content
OpenTrials

Clinical trial condition

BRCA1 Mutation

Explore clinical trials studying BRCA1 Mutation. Study availability and eligibility vary by location and protocol.

40 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

BRCA1 Mutation trial results

Recruiting

Registry of Subjects at Risk of Pancreatic Cancer

NCT04095195

Conditions
BRCA1 Mutation, BRCA2 Mutation, Colonic Diseases, +34 more
Locations
  • Istituto Clinico Humanitas Rozzano, Milan, Italy
  • Ospedale Pederzoli Peschiera del Garda, Verona, Italy
  • San Raffele Vita Salute University Hospital Milan, Italy
  • Chirurgia Generale e del Pancreas Verona, Italy
View Trial Details
Enrolling by invitation

Genetic Education in BRCA Families

NCT03544983

Conditions
Adnexal Diseases, BRCA1 Mutation, BRCA2 Mutation, +23 more
Locations
  • Georgetown University Medical Center/Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • George Washington University Washington D.C., District of Columbia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Geisinger Medical Center Danville, Pennsylvania, United States
View Trial Details
Active, not recruiting

Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors

NCT06380660

Conditions
Adnexal Diseases, BRCA1 Mutation, BRCA2 Mutation, +27 more
Locations
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
  • Anyang Cancer Hospital Anyang, Henan, China
View all 14 locations
View Trial Details
Active, not recruiting

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

NCT05498272

Conditions
BRCA1 Mutation, BRCA2 Mutation, Genital Diseases, +12 more
Locations
  • University of California San Diego - Moores Cancer Center La Jolla, California, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Columbia University Irving Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, not recruiting

FaCT Trial (Facilitated Cascade Testing Trial)

NCT04613440

Conditions
BRCA1 Mutation, BRCA2 Mutation, Fanconi Anemia, Complementation Group D1
Locations
  • Weill Cornell Medicine New York, United States
  • Duke University Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, not recruiting

BRCA Founder OutReach (BFOR) Study

NCT03351803

Conditions
BRCA1 Mutation, BRCA2 Mutation
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Memorial Sloan - Kettering Cancer Center New York, United States
View Trial Details

Related conditions